Get startedLog in
    Picture of Annexin Pharmaceuticals AB (publ) logo

    ANNX — Annexin Pharmaceuticals AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Annexin Gets Approval For Phase 2A Study In Diabetic Retinopathy, RVO

    Picture of Annexin Pharmaceuticals AB (publ) logoAnnexin Pharmaceuticals AB (publ)
    07/08/2025 07:34
    Aug 7 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST:

ANNEXIN RECEIVES APPROVAL FOR PHASE 2A STUDY IN DIABETIC RETINOPATHY AND RVO

Source text: ID:nMFN8dgDRT

Further company coverage: ANNX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Annexin Pharmaceuticals AB (publ)

    See all news